nicardipine has been researched along with Hypotension in 28 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of nicardipine-, nitroglycerin-, and prostaglandine E1-induced hypotension on cerebrovascular carbon dioxide (CO2) reactivity over a wide range of arterial CO2 tension (PaCO2) (PaCO2; range 25 to 50 mmHg)." | 9.09 | Effects of nicardipine-, nitroglycerin-, and prostaglandin E1-induced hypotension on human cerebrovascular carbon dioxide reactivity during propofol-fentanyl anesthesia. ( Endoh, H; Honda, T; Komura, N; Shibue, C; Shimoji, K; Watanabe, I, 1999) |
| "We compared the efficacy of the combination of enalaprilat/labetalol with that of enalaprilat/nicardipine to prevent emergence postcraniotomy hypertension." | 9.09 | A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery. ( Broad, C; Ferri, E; Kross, RA; Leung, D; Melendez, JA; Pratila, M; Veronesi, M, 2000) |
| "A placebo-controlled, double-blind multicenter trial was conducted in 123 patients with severe hypertension to examine the efficacy and safety of intravenously administered nicardipine hydrochloride in controlling blood pressure." | 9.06 | Intravenous nicardipine for the treatment of severe hypertension. A double-blind, placebo-controlled multicenter trial. ( Cheung, DG; Cook, ME; Davis, WR; Fletcher, E; Langford, HG; MacCarthy, EP; Ram, CV; Saunders, E; Townsend, R; Wallin, JD, 1989) |
| "Nicardipine is a potent drug to control hypertension during pregnancy with side effects including maternal headaches, nausea and tachycardia." | 8.90 | The optimal treatment of severe hypertension in pregnancy: update of the role of nicardipine. ( de Groot, CJ; Meuleman, T; Nooij, LS; Roelofs, R; Visser, S; Vos, P, 2014) |
| "In patients with hemorrhagic stroke, nicardipine appeared to have similar efficacy as clevidipine in SBP reduction, with a more likely reduction of rebound hypertension and drug cost." | 8.12 | Comparison of Clevidipine and Nicardipine for Acute Blood Pressure Reduction in Hemorrhagic Stroke. ( Breslin, J; Hanify, J; Heierman, T; Larizadeh, K; Phipps, W; Saldana, S; Sanchez, M, 2022) |
| "This multicenter, retrospective case series included all pregnant women beyond 20 weeks of gestation with severe antepartum hypertension that were treated with intravenous nicardipine." | 8.12 | Nicardipine for treating severe antepartum hypertension during pregnancy: Nine years of experience in more than 800 women. ( Cornette, JC; Duvekot, JJ; Edens, MA; Hengst, M; Huigen, S; Nij Bijvank, SW; Winkelen, AV, 2022) |
| "Patients were eligible if they had a diagnosis of an acute stroke and were administered either CIV-labetalol or CIV-nicardipine." | 8.02 | Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine? ( El-Ghoroury, H; Hecht, JP; Sudekum, DM, 2021) |
| "Nicardipine was associated with an increased risk of short-term mortality after acute ischemic stroke." | 7.91 | Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke. ( Desai, A; Hanni, C; Mohamed, W; Parker, D; Saber, H; Sadeghi, M; Singh, A, 2019) |
| "Intra-arterial (IA) nicardipine is often used to treat cerebral vasospasm associated with subarachnoid hemorrhage (SAH)." | 7.77 | High-dose intra-arterial nicardipine results in hypotension following vasospasm treatment in subarachnoid hemorrhage. ( Lazzaro, MA; Lopes, DK; Prabhakaran, S; Rosenberg, N, 2011) |
| "We concluded that cerebrovascular CO2 reactivity in insulin-dependent patients is impaired during nicardipine-induced hypotension under sevoflurane anesthesia." | 7.74 | Effects of nicardipine-induced hypotension on cerebrovascular carbon dioxide reactivity in patients with diabetes mellitus under sevoflurane anesthesia. ( Goto, F; Kadoi, Y, 2007) |
| "Nicardipine, a dihydropyridine type calcium channel blocker, was infused at two flow-rates into spontaneously hypertensive (SH) and control normotensive Wistar-Kyoto (WKY) rats (young, 6-week-old and adult, 23-week-old, n = 5) under pentobarbital anesthesia, to cause hypotension." | 7.70 | Changes of plasma L-arginine levels in spontaneously hypertensive rats under induced hypotension. ( Fukushima, T; Homma, H; Imai, K; Kasai, C; Matsunaga, H; Mori, T; Prados, P; Santa, T, 1999) |
| "Hepatic blood flow (HBF) and energy metabolism during moderate hypotension induced by prostaglandin E1 (PGE1) and nicardipine were studied by in vivo magnetic resonance spectroscopy." | 7.68 | Hepatic blood flow and energy metabolism during hypotension induced by prostaglandin E1 and nicardipine in rabbits: an in vivo magnetic resonance spectroscopic study. ( Arai, T; Inubushi, T; Kito, K; Mori, K; Morikawa, S, 1993) |
| "To induce deliberate hypotension during anesthesia, nicardipine was administered to patients undergoing total hip arthroplasty and was randomly compared with nitroprusside." | 7.68 | Deliberate hypotension with nicardipine or nitroprusside during total hip arthroplasty. ( Babin, M; Bernard, JM; François, T; Letenneur, J; Macquin-Mavier, I; Pinaud, M, 1991) |
| "Hemodynamic features of hypotension induced by nicardipine were studied in 18 mongrel dogs under 0." | 7.68 | [Hemodynamic features of hypotension induced by nicardipine in dogs]. ( Hosoyamada, A; Inada, Y; Matsui, K; Negishi, H; Takeda, S; Tashiro, N; Tomaru, T, 1990) |
| "Hypotension was the main side effect, and it occurred only in the two groups that received the highest doses." | 6.67 | Nicardipine in the prevention of spasm-induced neurological deficits after subarachnoid hemorrhage: a dose-ranging study. ( Bourdeix, I; Chaumet-Riffaud, P; Massiou, H, 1992) |
| "To investigate the effects of nicardipine-, nitroglycerin-, and prostaglandine E1-induced hypotension on cerebrovascular carbon dioxide (CO2) reactivity over a wide range of arterial CO2 tension (PaCO2) (PaCO2; range 25 to 50 mmHg)." | 5.09 | Effects of nicardipine-, nitroglycerin-, and prostaglandin E1-induced hypotension on human cerebrovascular carbon dioxide reactivity during propofol-fentanyl anesthesia. ( Endoh, H; Honda, T; Komura, N; Shibue, C; Shimoji, K; Watanabe, I, 1999) |
| "We compared the efficacy of the combination of enalaprilat/labetalol with that of enalaprilat/nicardipine to prevent emergence postcraniotomy hypertension." | 5.09 | A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery. ( Broad, C; Ferri, E; Kross, RA; Leung, D; Melendez, JA; Pratila, M; Veronesi, M, 2000) |
| "A placebo-controlled, double-blind multicenter trial was conducted in 123 patients with severe hypertension to examine the efficacy and safety of intravenously administered nicardipine hydrochloride in controlling blood pressure." | 5.06 | Intravenous nicardipine for the treatment of severe hypertension. A double-blind, placebo-controlled multicenter trial. ( Cheung, DG; Cook, ME; Davis, WR; Fletcher, E; Langford, HG; MacCarthy, EP; Ram, CV; Saunders, E; Townsend, R; Wallin, JD, 1989) |
| "Nicardipine is a potent drug to control hypertension during pregnancy with side effects including maternal headaches, nausea and tachycardia." | 4.90 | The optimal treatment of severe hypertension in pregnancy: update of the role of nicardipine. ( de Groot, CJ; Meuleman, T; Nooij, LS; Roelofs, R; Visser, S; Vos, P, 2014) |
| "In patients with hemorrhagic stroke, nicardipine appeared to have similar efficacy as clevidipine in SBP reduction, with a more likely reduction of rebound hypertension and drug cost." | 4.12 | Comparison of Clevidipine and Nicardipine for Acute Blood Pressure Reduction in Hemorrhagic Stroke. ( Breslin, J; Hanify, J; Heierman, T; Larizadeh, K; Phipps, W; Saldana, S; Sanchez, M, 2022) |
| "This multicenter, retrospective case series included all pregnant women beyond 20 weeks of gestation with severe antepartum hypertension that were treated with intravenous nicardipine." | 4.12 | Nicardipine for treating severe antepartum hypertension during pregnancy: Nine years of experience in more than 800 women. ( Cornette, JC; Duvekot, JJ; Edens, MA; Hengst, M; Huigen, S; Nij Bijvank, SW; Winkelen, AV, 2022) |
| "Patients were eligible if they had a diagnosis of an acute stroke and were administered either CIV-labetalol or CIV-nicardipine." | 4.02 | Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine? ( El-Ghoroury, H; Hecht, JP; Sudekum, DM, 2021) |
| "Nicardipine was associated with an increased risk of short-term mortality after acute ischemic stroke." | 3.91 | Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke. ( Desai, A; Hanni, C; Mohamed, W; Parker, D; Saber, H; Sadeghi, M; Singh, A, 2019) |
| "Intra-arterial (IA) nicardipine is often used to treat cerebral vasospasm associated with subarachnoid hemorrhage (SAH)." | 3.77 | High-dose intra-arterial nicardipine results in hypotension following vasospasm treatment in subarachnoid hemorrhage. ( Lazzaro, MA; Lopes, DK; Prabhakaran, S; Rosenberg, N, 2011) |
| "We concluded that cerebrovascular CO2 reactivity in insulin-dependent patients is impaired during nicardipine-induced hypotension under sevoflurane anesthesia." | 3.74 | Effects of nicardipine-induced hypotension on cerebrovascular carbon dioxide reactivity in patients with diabetes mellitus under sevoflurane anesthesia. ( Goto, F; Kadoi, Y, 2007) |
| " This study was designed to investigate the acute effects of local application of a SMF to neck or pelvic region under pharmacologically modulated BP; norepinephrine (NE)-induced hypertension as well as an L-type voltage-gated Ca(2+) channel blocker, nicardipine (NIC)-induced hypotension in conscious rabbits." | 3.73 | Effects of neck exposure to 5.5 mT static magnetic field on pharmacologically modulated blood pressure in conscious rabbits. ( Ohkubo, C; Okano, H, 2005) |
| " Nicardipine provides a good control of vasoconstriction during phaeochromocytoma surgery with limited risk of serious hypotension after tumour removal." | 3.70 | Haemodynamic heterogeneity and treatment with the calcium channel blocker nicardipine during phaeochromocytoma surgery. ( Colson, P; Dareau, S; Mann, C; Ribstein, J; Ryckwaert, F, 1998) |
| "Nicardipine, a dihydropyridine type calcium channel blocker, was infused at two flow-rates into spontaneously hypertensive (SH) and control normotensive Wistar-Kyoto (WKY) rats (young, 6-week-old and adult, 23-week-old, n = 5) under pentobarbital anesthesia, to cause hypotension." | 3.70 | Changes of plasma L-arginine levels in spontaneously hypertensive rats under induced hypotension. ( Fukushima, T; Homma, H; Imai, K; Kasai, C; Matsunaga, H; Mori, T; Prados, P; Santa, T, 1999) |
| "To induce deliberate hypotension during anesthesia, nicardipine was administered to patients undergoing total hip arthroplasty and was randomly compared with nitroprusside." | 3.68 | Deliberate hypotension with nicardipine or nitroprusside during total hip arthroplasty. ( Babin, M; Bernard, JM; François, T; Letenneur, J; Macquin-Mavier, I; Pinaud, M, 1991) |
| "Hepatic blood flow (HBF) and energy metabolism during moderate hypotension induced by prostaglandin E1 (PGE1) and nicardipine were studied by in vivo magnetic resonance spectroscopy." | 3.68 | Hepatic blood flow and energy metabolism during hypotension induced by prostaglandin E1 and nicardipine in rabbits: an in vivo magnetic resonance spectroscopic study. ( Arai, T; Inubushi, T; Kito, K; Mori, K; Morikawa, S, 1993) |
| "Hemodynamic features of hypotension induced by nicardipine were studied in 18 mongrel dogs under 0." | 3.68 | [Hemodynamic features of hypotension induced by nicardipine in dogs]. ( Hosoyamada, A; Inada, Y; Matsui, K; Negishi, H; Takeda, S; Tashiro, N; Tomaru, T, 1990) |
| "Intracerebroventricular injections of nicardipine (10 micrograms/kg) to SHR induced hypotension which was suppressed by pretreatment with 6-OHDA." | 3.67 | Endogenous opiate system and dihydropyridine-induced central regulation of sympathetic tone in rats. ( Brisac, AM; Champeroux, P; Laurent, S; Schmitt, H, 1988) |
| "Hypotension was the main side effect, and it occurred only in the two groups that received the highest doses." | 2.67 | Nicardipine in the prevention of spasm-induced neurological deficits after subarachnoid hemorrhage: a dose-ranging study. ( Bourdeix, I; Chaumet-Riffaud, P; Massiou, H, 1992) |
| "Outcome of patients with aneurysmal subarachnoid hemorrhage (SAH) has improved over the last decades." | 2.49 | SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials. ( Cusimano, MD; Etminan, N; Hanggi, D; Hasan, D; Ilodigwe, D; Jaja, B; Lantigua, H; Le Roux, P; Lo, B; Louffat-Olivares, A; Macdonald, RL; Mayer, S; Molyneux, A; Quinn, A; Schenk, T; Schweizer, TA; Singh, J; Spears, J; Todd, M; Torner, J; Vergouwen, MD; Wong, GK, 2013) |
| "We present a case of neurogenic stunned myocardium, discovered intraoperatively after anesthetic induction, in a patient who presented to our operating room with a recent intraparenchymal hemorrhage." | 1.43 | Prolonged Cardiac Dysfunction After Intraparenchymal Hemorrhage and Neurogenic Stunned Myocardium. ( Krishnamoorthy, V; Sharma, D; Vavilala, MS; Wilson, T, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.14) | 18.7374 |
| 1990's | 10 (35.71) | 18.2507 |
| 2000's | 4 (14.29) | 29.6817 |
| 2010's | 8 (28.57) | 24.3611 |
| 2020's | 4 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Saldana, S | 1 |
| Breslin, J | 1 |
| Hanify, J | 1 |
| Heierman, T | 1 |
| Larizadeh, K | 1 |
| Sanchez, M | 1 |
| Phipps, W | 1 |
| Nij Bijvank, SW | 1 |
| Hengst, M | 1 |
| Cornette, JC | 1 |
| Huigen, S | 1 |
| Winkelen, AV | 1 |
| Edens, MA | 1 |
| Duvekot, JJ | 1 |
| Ibarra, F | 1 |
| Holzmann, S | 1 |
| Shah, S | 1 |
| Fountain, C | 1 |
| Saleh, S | 1 |
| Kapoor, V | 1 |
| Dang, T | 1 |
| El-Ghoroury, H | 1 |
| Sudekum, DM | 1 |
| Hecht, JP | 1 |
| Sadeghi, M | 1 |
| Saber, H | 1 |
| Singh, A | 1 |
| Hanni, C | 1 |
| Parker, D | 1 |
| Desai, A | 1 |
| Mohamed, W | 1 |
| Macdonald, RL | 1 |
| Jaja, B | 1 |
| Cusimano, MD | 1 |
| Etminan, N | 1 |
| Hanggi, D | 1 |
| Hasan, D | 1 |
| Ilodigwe, D | 1 |
| Lantigua, H | 1 |
| Le Roux, P | 1 |
| Lo, B | 1 |
| Louffat-Olivares, A | 1 |
| Mayer, S | 1 |
| Molyneux, A | 1 |
| Quinn, A | 1 |
| Schweizer, TA | 1 |
| Schenk, T | 1 |
| Spears, J | 1 |
| Todd, M | 1 |
| Torner, J | 1 |
| Vergouwen, MD | 1 |
| Wong, GK | 1 |
| Singh, J | 1 |
| Nooij, LS | 1 |
| Visser, S | 1 |
| Meuleman, T | 1 |
| Vos, P | 1 |
| Roelofs, R | 1 |
| de Groot, CJ | 1 |
| Lhommet, P | 1 |
| Espitalier, F | 1 |
| Merlini, T | 1 |
| Marchand, E | 1 |
| Aupart, M | 1 |
| Martinez, R | 1 |
| Krishnamoorthy, V | 1 |
| Wilson, T | 1 |
| Sharma, D | 1 |
| Vavilala, MS | 1 |
| Kurowski, D | 1 |
| Mullen, MT | 1 |
| Messé, SR | 1 |
| Rosenberg, N | 1 |
| Lazzaro, MA | 1 |
| Lopes, DK | 1 |
| Prabhakaran, S | 1 |
| Haile, M | 1 |
| Galoyan, S | 1 |
| Li, YS | 1 |
| Cohen, BH | 1 |
| Quartermain, D | 1 |
| Blanck, T | 1 |
| Bekker, A | 1 |
| Shinozuka, K | 1 |
| Umegaki, K | 1 |
| Kubota, Y | 1 |
| Tanaka, N | 1 |
| Mizuno, H | 1 |
| Yamauchi, J | 1 |
| Nakamura, K | 1 |
| Kunitomo, M | 1 |
| Okano, H | 1 |
| Ohkubo, C | 1 |
| Kadoi, Y | 1 |
| Goto, F | 1 |
| Connelly, CM | 1 |
| Waksmonski, C | 1 |
| Gagnon, MM | 1 |
| Lipsitz, LA | 1 |
| Kito, K | 1 |
| Arai, T | 1 |
| Mori, K | 1 |
| Morikawa, S | 1 |
| Inubushi, T | 1 |
| Balakumaran, A | 1 |
| Campbell, GA | 1 |
| Moslen, MT | 1 |
| Colson, P | 1 |
| Ryckwaert, F | 1 |
| Ribstein, J | 1 |
| Mann, C | 1 |
| Dareau, S | 1 |
| Prados, P | 1 |
| Matsunaga, H | 1 |
| Mori, T | 1 |
| Santa, T | 1 |
| Fukushima, T | 1 |
| Homma, H | 1 |
| Kasai, C | 1 |
| Imai, K | 1 |
| Endoh, H | 1 |
| Honda, T | 1 |
| Komura, N | 1 |
| Shibue, C | 1 |
| Watanabe, I | 1 |
| Shimoji, K | 1 |
| Kross, RA | 1 |
| Ferri, E | 1 |
| Leung, D | 1 |
| Pratila, M | 1 |
| Broad, C | 1 |
| Veronesi, M | 1 |
| Melendez, JA | 1 |
| Morooka, H | 1 |
| Gotoh, S | 1 |
| Makita, T | 1 |
| Fukuzaki, M | 1 |
| Shibata, O | 1 |
| Gotoh, Y | 1 |
| Massiou, H | 1 |
| Chaumet-Riffaud, P | 1 |
| Bourdeix, I | 1 |
| Bernard, JM | 1 |
| Pinaud, M | 1 |
| François, T | 1 |
| Babin, M | 1 |
| Macquin-Mavier, I | 1 |
| Letenneur, J | 1 |
| Takeda, S | 1 |
| Inada, Y | 1 |
| Tashiro, N | 1 |
| Matsui, K | 1 |
| Tomaru, T | 1 |
| Negishi, H | 1 |
| Hosoyamada, A | 1 |
| Wallin, JD | 1 |
| Fletcher, E | 1 |
| Ram, CV | 1 |
| Cook, ME | 1 |
| Cheung, DG | 1 |
| MacCarthy, EP | 1 |
| Townsend, R | 1 |
| Saunders, E | 1 |
| Davis, WR | 1 |
| Langford, HG | 1 |
| Champeroux, P | 1 |
| Brisac, AM | 1 |
| Laurent, S | 1 |
| Schmitt, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficiency of Intravenous Lidocaine to Reduce Coughing and the Hemodynamic Changes Associated to Tracheal Extubation[NCT03731429] | Phase 4 | 144 participants (Anticipated) | Interventional | 2019-04-05 | Recruiting | ||
| Nicardipine Versus Esmolol for Management of Emergence Hypertension After Craniotomy[NCT01951950] | Phase 1 | 40 participants (Actual) | Interventional | 2013-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT01951950)
Timeframe: 1 hour postoperatively
| Intervention | participants (Number) |
|---|---|
| Nicardipine | 1 |
| Esmolol | 11 |
2 reviews available for nicardipine and Hypotension
| Article | Year |
|---|---|
SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.
Topics: Antioxidants; Brain Infarction; Calcium Channel Blockers; Critical Care; Dioxanes; Drug Therapy, Com | 2013 |
The optimal treatment of severe hypertension in pregnancy: update of the role of nicardipine.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Hypotension; Infant, Newborn; Labetalol; Nica | 2014 |
5 trials available for nicardipine and Hypotension
21 other studies available for nicardipine and Hypotension
| Article | Year |
|---|---|
Comparison of Clevidipine and Nicardipine for Acute Blood Pressure Reduction in Hemorrhagic Stroke.
Topics: Acute Kidney Injury; Adult; Antihypertensive Agents; Blood Pressure; Bradycardia; Hematoma; Hemorrha | 2022 |
Nicardipine for treating severe antepartum hypertension during pregnancy: Nine years of experience in more than 800 women.
Topics: Antihypertensive Agents; Blood Pressure; Cesarean Section; Female; Humans; Hypertension; Hypotension | 2022 |
Utility of nicardipine in the management of hypertensive crises in adults with reduced ejection fractions.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Bradycardia; Heart Failure; Humans; Hypertension; Hy | 2024 |
Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine?
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pre | 2021 |
Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Brain Ischemia; Critical Illness; Databases, Factual; | 2019 |
Tolerance of rapid right ventricular pacing during thoracic endovascular aortic repair.
Topics: Aged; Aorta, Thoracic; Aortic Diseases; Biomarkers; Blood Vessel Prosthesis Implantation; Cardiac Pa | 2015 |
Prolonged Cardiac Dysfunction After Intraparenchymal Hemorrhage and Neurogenic Stunned Myocardium.
Topics: Adult; Anesthesia, General; Cerebral Hemorrhage; Emergency Service, Hospital; Heart; Hemangioma, Cav | 2016 |
Pearls & Oy-sters: Iatrogenic relative hypotension leading to diffuse internal borderzone infarctions and coma.
Topics: Adult; Antihypertensive Agents; Brain Infarction; Coma; Diffusion Magnetic Resonance Imaging; Fatal | 2016 |
High-dose intra-arterial nicardipine results in hypotension following vasospasm treatment in subarachnoid hemorrhage.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cerebral Angiography; Circle of Willis; Dose-Respons | 2011 |
Nimodipine-induced hypotension but not nitroglycerin-induced hypotension preserves long- and short-term memory in adult mice.
Topics: Animals; Avoidance Learning; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Cer | 2012 |
Feeding of Ginkgo biloba extract (GBE) enhances gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats.
Topics: Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Cytochrome P-450 Enzyme System; Diet; D | 2002 |
Effects of neck exposure to 5.5 mT static magnetic field on pharmacologically modulated blood pressure in conscious rabbits.
Topics: Animals; Baroreflex; Blood Pressure; Bradycardia; Calcium Channel Blockers; Carotid Sinus; Conscious | 2005 |
Effects of nicardipine-induced hypotension on cerebrovascular carbon dioxide reactivity in patients with diabetes mellitus under sevoflurane anesthesia.
Topics: Aged; Anesthetics, Inhalation; Antihypertensive Agents; Blood Pressure; Carbon Dioxide; Cerebrovascu | 2007 |
Hepatic blood flow and energy metabolism during hypotension induced by prostaglandin E1 and nicardipine in rabbits: an in vivo magnetic resonance spectroscopic study.
Topics: Adenosine Triphosphate; Alprostadil; Animals; Blood Pressure; Energy Metabolism; Hypotension; Liver; | 1993 |
Calcium channel blockers induce thymic apoptosis in vivo in rats.
Topics: Animals; Apoptosis; Calcium Channel Blockers; Chlorpromazine; Diltiazem; Dopamine Antagonists; Dose- | 1996 |
Haemodynamic heterogeneity and treatment with the calcium channel blocker nicardipine during phaeochromocytoma surgery.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Arrhythmias, Cardiac; Calcium Channel Blockers; Female; Hemody | 1998 |
Changes of plasma L-arginine levels in spontaneously hypertensive rats under induced hypotension.
Topics: Animals; Antihypertensive Agents; Arginine; Calcium Channel Blockers; Hypertension; Hypotension; Mal | 1999 |
[Adrenal catecholamine releases during hypotension with continuous administration of calcium entry blockers and nitroglycerin].
Topics: Adrenal Glands; Animals; Diltiazem; Dogs; Epinephrine; Hypotension; Male; Nicardipine; Nitroglycerin | 1992 |
Deliberate hypotension with nicardipine or nitroprusside during total hip arthroplasty.
Topics: Aged; Anesthesia, Inhalation; Epinephrine; Female; Fentanyl; Hemodynamics; Hip Prosthesis; Humans; H | 1991 |
[Hemodynamic features of hypotension induced by nicardipine in dogs].
Topics: Animals; Dogs; Hemodynamics; Hypotension; Nicardipine | 1990 |
Endogenous opiate system and dihydropyridine-induced central regulation of sympathetic tone in rats.
Topics: Animals; Blood Pressure; Dihydropyridines; Endorphins; Hydroxydopamines; Hypotension; Male; Naloxone | 1988 |